Ben Worthen of The Wall Street Journal, interviewed Randall Spratt, chief information officer at McKesson Corp. McKesson was ...

Valued at a market cap of $80.4 billion, McKesson Corporation (MCK) is a leading healthcare services and information ...

Connor Clark & Lunn Investment Management Ltd. grew its holdings in McKesson Co. (NYSE:MCK – Free Report) by 300.6% during ...

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter ...

With a market cap of $75.6 billion, McKesson delivers pharmaceuticals, medical supplies, and technology solutions that enhance healthcare efficiency and patient outcomes, supporting pharmacies ...

Its Prescription Technology Solutions segment aims to enhance medication access and affordability. In recent years, McKesson has focused on strengthening its core operations in the U.S. and Canada ...

McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net income. The company also emphasizes the development of the RxTS segment ...

To get a sense of who is truly in control of McKesson Corporation (NYSE:MCK), it is important to understand the ownership structure of the business. The group holding the most number of shares in ...

Valued at a market cap of $80.4 billion, McKesson Corporation (MCK) is a leading healthcare services and information technology company. The Irving, Texas-based company operates through four ...